These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26018436)

  • 1. Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism.
    Hardcastle MR; Dittmer KE
    Vet Pathol; 2015 Sep; 52(5):770-84. PubMed ID: 26018436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forging forward with 10 burning questions on FGF23 in kidney disease.
    Wolf M
    J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23 and the parathyroid glands.
    Silver J; Naveh-Many T
    Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fibroblast growth factor 23 concentrations in dogs with chronic kidney disease.
    Dittmer KE; Perera KC; Elder PA
    Res Vet Sci; 2017 Oct; 114():348-350. PubMed ID: 28667925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.
    Perwad F; Portale AA
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):17-24. PubMed ID: 21914460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism].
    Bacchetta J; Cochat P; Salusky IB
    Arch Pediatr; 2011 Jun; 18(6):686-95. PubMed ID: 21497493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
    Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23-parathyroid interaction: implications in chronic kidney disease.
    Komaba H; Fukagawa M
    Kidney Int; 2010 Feb; 77(4):292-8. PubMed ID: 20010546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
    Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23: its role in renal bone disease.
    Fukagawa M; Kazama JJ
    Pediatr Nephrol; 2006 Dec; 21(12):1802-6. PubMed ID: 16932898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What would we like to know, and what do we not know about fibroblast growth factor 23?
    Cozzolino M; Galassi A; Apetrii M; Covic A
    J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatonin pathway: new insights in phosphate homeostasis.
    Schiavi SC; Kumar R
    Kidney Int; 2004 Jan; 65(1):1-14. PubMed ID: 14675031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.